氟西汀治疗应答的基因表达特征:系统综述与荟萃分析
该研究按PRISMA指南检索GEO数据库,系统再分析氟西汀治疗的人类与啮齿类基因表达数据,共纳入20个数据集(18个啮齿类、2个人类)。应答者与非应答者间有18条通路一致差异,包括Toll样受体(TLR)等免疫通路;信号转导通路在抑郁患者和啮齿模型中一致受氟西汀影响。
要点
- 应答者与非应答者间18条通路一致差异,涉及TLR等免疫通路。
- 信号转导通路在抑郁患者和啮齿模型中一致受氟西汀治疗影响。
- 纳入研究异质性高,多数为啮齿模型,人类研究样本量小。
核心结论
- 荟萃分析确认了已知通路,并为抗抑郁药抵抗提供了新线索,但需更多研究。
研究设计与样本
- 遵循PRISMA指南检索GEO数据库,纳入氟西汀治疗抑郁或焦虑相关的人类或啮齿类基因表达研究。
- 排除非抑郁或焦虑背景、无关组织类型或每组少于三个样本的研究。
- 纳入研究经差异表达分析和基因集富集分析(GSEA)系统再分析,通路与基因统计采用三种p值合并方法并校正错误发现。
主要发现
- 筛选74个数据集,纳入20个:18个啮齿类、2个人类患者组织。
- 治疗 vs 对照比较中,691条通路在至少一项研究中显著差异。
- 应答者 vs 非应答者比较中,357条通路在至少一项研究中显著差异。
- 应答者与非应答者间有18条通路一致差异,包括Toll样受体(TLR)和其他免疫通路。
- 信号转导通路在抑郁患者和啮齿模型中一致受氟西汀治疗影响。
临床怎么用
- TLR等免疫通路和信号转导通路可作为氟西汀应答或抵抗的潜在生物标志物方向进一步验证。
局限性
- 纳入研究在治疗 vs 对照和应答者 vs 非应答者比较中异质性高。
- 多数纳入研究为啮齿模型,两项人类研究队列小。
- 需更多采用其他组学技术的大队列研究来理解抗抑郁应答的复杂性与异质性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Genomic (and other 'omic) data have provided valuable insights on the pharmacological signatures of antidepressant response, but results from individual studies are largely heterogeneous. In this work, we synthesized gene expression data for fluoxetine treatment in both human patients and rodent models, to better understand biological pathways affected by treatment, as well as those that may distinguish clinical or behavioral response. METHODS: Following the PRISMA guidelines, we searched the Gene Expression Omnibus (GEO) for studies profiling humans or rodent models with treatment of the antidepressant fluoxetine, excluding those not done in the context of depression or anxiety, in an irrelevant tissue type, or with fewer than three samples per group. Included studies were systematically reanalyzed by differential expression analysis and Gene Set Enrichment Analysis (GSEA). Individual pathway and gene statistics were synthesized across studies by three p-value combination methods, and then corrected for false discovery. RESULTS: Of the 74 data sets that were screened, 20 were included: 18 in rodents, and two in tissue from human patients. Studies were highly heterogeneous in the comparisons of both treated vs. control samples and responders vs. non-responders, with 691 and 357 pathways, respectively, identified as significantly different between groups in at least one study. However, 18 pathways were identified as consistently different in responders vs. non-responders, including toll-like receptor (TLR) and other immune pathways. Signal transduction pathways were identified as consistently affected by fluoxetine treatment in depressed patients and rodent models. DISCUSSION: These meta-analyses confirm known pathways and provide new hints toward antidepressant resistance, but more work is needed. Most included studies involved rodent models, and both patient studies had small cohorts. Additional large-cohort studies applying additional 'omics technologies are necessary to understand the intricacies and heterogeneity of antidepressant response.
引用
- Cooper DG, Cowden JP, Vo PM, et al. Gene expression signatures of response to fluoxetine treatment: systematic review and meta-analyses. Mol Psychiatry. 2025. PMID: 40676137. doi:10.1038/s41380-025-03118-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。